Locksflooring,
You seem to have taken my place as moderator for this board, so you must feel that you know more about this company and possibly the industry, what are your thoughts on why this company's stock is trading today at a new 52 week high? Also, any predictions on their upcoming announcements?
GLTY,
Stockinvestor
Bio-Rad Laboratories, Inc. (BIO)
$ 111.99 ?1.87 (1.70%)
Volume: 33,248
Bid (USD) Ask (USD) Last Traded Open Prev Close
111.97 112.03 2:40:44 PM EDT 110.45 110.12
Day's Range 52-Wk Range Avg Volume EPS P/E
109.90 - 112.18 66.70 - 110.46
You seem to have taken my place as moderator for this board, so you must feel that you know more about this company and possibly the industry, what are your thoughts on why this company's stock is trading today at a new 52 week high? Also, any predictions on their upcoming announcements?
GLTY,
Stockinvestor
Bio-Rad Laboratories, Inc. (BIO)
$ 111.99 ?1.87 (1.70%)
Volume: 33,248
Bid (USD) Ask (USD) Last Traded Open Prev Close
111.97 112.03 2:40:44 PM EDT 110.45 110.12
Day's Range 52-Wk Range Avg Volume EPS P/E
109.90 - 112.18 66.70 - 110.46
Recent BIO News
- Bio-Rad to Participate in Upcoming Investor Conferences • Business Wire • 05/08/2026 01:00:00 PM
- Bio-Rad Reports First-Quarter 2026 Financial Results • Business Wire • 04/30/2026 08:15:00 PM
- Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 • Business Wire • 04/16/2026 08:15:00 PM
- Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results • Business Wire • 02/12/2026 09:15:00 PM
- Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 • Business Wire • 01/29/2026 01:30:00 PM
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference • Business Wire • 01/06/2026 01:45:00 PM
- Bio-Rad Reports Third-Quarter 2025 Financial Results • Business Wire • 10/29/2025 08:15:00 PM
- Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 • Business Wire • 10/16/2025 09:30:00 PM
- Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away • Business Wire • 09/30/2025 12:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 10:03:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 10:03:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 10:02:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2025 10:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 01:00:36 PM
- Bio-Rad's Management to Participate in Upcoming Investor Conferences • Business Wire • 08/25/2025 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2025 09:37:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/05/2025 08:47:16 PM
- Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025 • Business Wire • 08/01/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/31/2025 08:17:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2025 08:15:57 PM
- Bio-Rad Reports Second-Quarter 2025 Financial Results • Business Wire • 07/31/2025 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/29/2025 09:20:56 PM
- Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations • Business Wire • 07/28/2025 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/28/2025 08:14:54 PM
